Intuitive Surgical price target lowered to $390 from $400 at Citi

Citi lowered the firm’s price target on Intuitive Surgical to $390 from $400 and keeps a Buy rating on the shares post the Q3 report. The company reported a slight revenue miss on a shortfall in Systems sales, the analyst tells investors in a research note. The firm says that despite placing 312 systems, the percentage of leased versus sold systems significantly shifted, the analyst tells investors in a research note. It found Intuitive Surgical’s China and GLP commentary encouraging.